MoDC and CD1c+ and CD141+ BDC subsets upregulate OX40L when stimulated and produce pro-inflammatory cytokines necessary for T cell activation, supporting further in vivo studies to confirm that mature DC can be used to achieve anti-tumor responses in the same manner as agonistic OX40 mAbs. The gene discussed is TNFSF4; the disease is neoplasm.